Clinical Trials : Adenoviridae Infections

Completed

Study Name: Ad Sensor-based Real-time Diagnosis of Adenovirus
Condition: Adenovirus
Date: 2013-12-06
Interventions: Device: Ad sensor Ad sensor, which was developed for the r

Withdrawn

Study Name: Adenovirus Vaccine Pregnancy Registry
Condition: Adenovirus
Date: 2012-04-20

Available

Study Name: Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Condition: Adenovirus
Date: 2015-11-03
Interventions: Drug: Brincidofovir Up to 100mg Brincidofovir twice weekly, not to exceed a total dose of 200mg each wee

Completed

Study Name: Clinical Grade Adenovirus Specific T Cells for Immunotherapy After Allogeneic Stem Cell Transplantation (CTL-ADV)
Condition: Adenovirus Infection
Date: 2016-07-28
Interventions: Other: Infusion of ADV specific T cells Cell engineering

Terminated

Study Name: A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304
Condition: Adenovirus
Date: 2015-04-09
Interventions: Drug: Brincidofovir Rates of adenovirus progression and mortality in subjects with adenovirus infection

Not yet recruiting

Study Name: Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)
Condition: Adenovirus Infection
Date: 2014-10-20
Interventions: Biological: Viralym-A Follow-up Assessments: The timing of

Completed

Study Name: Ganciclovir 0,15% Ophthalmic Gel in the Treatment of Adenovirus Keratoconjuntivitis
Condition:

Conjunctivitis, Viral
Adenoviridae Infections

Date: 2011-04-29
Interventions:

Drug: Ganciclovir Ganciclovir

Completed

Study Name: Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection
Condition: Adenovirus Infection
Date: 2014-03-12
Interventions: Drug: CMX001 CMX001 administered twice weekly, dose depending on weight.

Withdrawn

Study Name: Adenovirus and Fungal Load in Pediatric Stem Cell Transplant Patients
Condition:

Adenovirus
Other Mycoses

Date: 2007-03-15

Withdrawn

Study Name: Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus
Condition:

Conjunctivitis
Adenovirus.

Date: 2011-03-22
Interventions:

Drug: Ophthalmic gel (placebo)

Search for Clinical Trial Results

Adenoviridae Infections - 138 Studies Found

Status	Study
Completed	Study Name: Ad Sensor-based Real-time Diagnosis of Adenovirus Condition: Adenovirus Date: 2013-12-06 Interventions: Device: Ad sensor Ad sensor, which was developed for the r
Withdrawn	Study Name: Adenovirus Vaccine Pregnancy Registry Condition: Adenovirus Date: 2012-04-20
Available	Study Name: Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease Condition: Adenovirus Date: 2015-11-03 Interventions: Drug: Brincidofovir Up to 100mg Brincidofovir twice weekly, not to exceed a total dose of 200mg each wee
Completed	Study Name: Clinical Grade Adenovirus Specific T Cells for Immunotherapy After Allogeneic Stem Cell Transplantation (CTL-ADV) Condition: Adenovirus Infection Date: 2016-07-28 Interventions: Other: Infusion of ADV specific T cells Cell engineering
Terminated	Study Name: A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304 Condition: Adenovirus Date: 2015-04-09 Interventions: Drug: Brincidofovir Rates of adenovirus progression and mortality in subjects with adenovirus infection
Not yet recruiting	Study Name: Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A) Condition: Adenovirus Infection Date: 2014-10-20 Interventions: Biological: Viralym-A Follow-up Assessments: The timing of
Completed	Study Name: Ganciclovir 0,15% Ophthalmic Gel in the Treatment of Adenovirus Keratoconjuntivitis Condition: Conjunctivitis, Viral Adenoviridae Infections Date: 2011-04-29 Interventions: Drug: Ganciclovir Ganciclovir
Completed	Study Name: Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection Condition: Adenovirus Infection Date: 2014-03-12 Interventions: Drug: CMX001 CMX001 administered twice weekly, dose depending on weight.
Withdrawn	Study Name: Adenovirus and Fungal Load in Pediatric Stem Cell Transplant Patients Condition: Adenovirus Other Mycoses Date: 2007-03-15
Withdrawn	Study Name: Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus Condition: Conjunctivitis Adenovirus. Date: 2011-03-22 Interventions: Drug: Ophthalmic gel (placebo)